pharma

Showing 15 posts of 2914 posts found.

celltrion1

Celltrion’s infliximab biosimilar Remsima secures European approval in five indications

July 27, 2020
Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima

The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …

shutterstock_273326141

AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal

July 27, 2020
Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020
Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …

800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …

abbvie_0

AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits

July 22, 2020
Research and Development AbbVie, atopic dermatits, pharma, upadacitinib

AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …

Is Pharma doing enough on sustainability?

July 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Doctor online

COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest

July 16, 2020
Medical Communications, Research and Development digital, healthcare, pharma

The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …

fdaoutsideweb

FDA committee backs GSK’s belantamab mafodotin in relapsed or refractory multiple myeloma

July 15, 2020
Research and Development, Sales and Marketing Cancer, FDA, GSK, multiple myeloma, pharma

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as …

shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020
Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …

shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020
Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …

J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos

July 9, 2020
Sales and Marketing Cancer, J&J, JJ, pharma, talc

In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …

takeda_world

Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates

July 1, 2020
Research and Development Takeda Carmine, partnership, pharma

Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …

fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020
Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …

shutterstock_273326141

Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal

June 24, 2020
Research and Development, Sales and Marketing Gilead, Pionyr, pharma

Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …

The Gateway to Local Adoption Series

Latest content